Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia-Reference-Cited by-同舟云学术

Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia

Published:2019-02-01 Issue:2 Volume:65 Page:225-227
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Sniderman Allan D¹

Affiliation:

1. McGill University Health Centre, McGill University, Montreal, Quebec

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/65/2/225/32638115/clinchem0225.pdf

Reference11 articles.

1. Fat transport in lipoproteins–an integrated approach to mechanisms and disorders;Fredrickson;N Engl J Med,1967

2. Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder;Koopal;Curr Opin Endocrinol Diabetes Obes,2017

3. Hyperlipoproteinemia type 3: the forgotten phenotype;Hopkins;Curr Atheroscler Rep,2014

4. The spectrum of type III hyperlipoproteinemia;Sniderman;J Clin Lipidol,2018

5. Evaluation of the non-HDL cholesterol to apolipoprotein B ratio as a screening test for dsybetalipoproteinemia;Boot;Clin Chem,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa;Journal of Neuroendocrinology;2024-06-10

2. Triglyceride-rich lipoprotein cholesterol and cardiovascular risk;Current Opinion in Lipidology;2023-09-29

3. Dietary recommendations for dysbetalipoproteinemia: A need for better evidence;Journal of Clinical Lipidology;2023-07

4. Hyperlipidemia and Cardiovascular Risk in Children and Adolescents;Biomedicines;2023-03-07

5. Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype;Clinical Chemistry;2023-01-16